No Data
No Data
Express News | Zyversa Therapeutics: Files for Prospectus Related to Offer & Resale of up to 1.6 Mln Shares of Common Stock by Selling Stockholder - SEC Filing
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Attend JPM's Healthcare Conference 2025 in San Francisco
ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
8-K: ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
Express News | ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate
Express News | Zyversa Therapeutics - Qtrly Loss per Share $2.43
TheGerries : So when is our turn?
Den the Dragon : ,
Jaguar8 OP TheGerries : ???
103622690 DK : I really admire you, and I'm curious how you pick your watchlist from so many options, and even repeatedly select those with upward trends, leading to explosive gains the next day... I really want to learn from you, Master. 🫡
Jaguar8 OP 103622690 DK : If I have time and teach during weekends. It also takes experience to get the feel which stock are quite positive . There are misses too but often times they go up in the next days
View more comments...